Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
What loving-kindness meditation is and how to practice it in the new year - 2Why haven’t humans been back to the moon in over 50 years?
- 3Vote in favor of your Number one Kind of Gems
- 4The most effective method to Distinguish the Best Material Organization in Your Space
- 5Kuwait is softening stance on Israel, dissident tells ‘Post’ after viral UN speech
- The Manual for Electric Vehicles that will be hot dealers in 2023
- Most loved Fish Dish: What's Your Sea Pleasure?
- Figure out How to Adjust Work, Life, and an Internet based Degree
- Instructions to Pick the Right Gold Speculation Procedure: Exploring the Market
- An Extended period of Voyaging Carefully: the World with Reason
- This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- Finding the Universe of Workmanship: Individual Encounters in Imagination
- Surveys of 6 Hot Savvy Beds
- Unwind: Four Extraordinary Spa Resorts On the planet
